Tumors derived from human cancer cells overexpressing a catalytically inactive RNASET2 protein were equally suppressed in their in vivo growth rate when compared to their wildtype RNASET2-expressing counterpart, suggesting that RNASET2-mediated tumor suppression is independent from its ribonuclease activity (57). This evidence concerns the gene RNASET2 and neoplasm.